XML 104 R88.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Deficit) - Additional Information (Details)
12 Months Ended
Dec. 29, 2025
shares
Apr. 07, 2020
USD ($)
shares
Dec. 31, 2025
USD ($)
item
tranche
$ / shares
Dec. 31, 2024
$ / shares
shares
Jan. 21, 2025
shares
Stockholders' Equity (Deficit)          
Common Stock, Capital Shares Reserved for Future Issuance | shares   83,750      
Number of executive officers entered into employment agreements | item     2    
Number of tranches in which the market-based grants vest | tranche     2    
Weighted average estimated grant date fair value | $ / shares     $ 10 $ 63  
Unrecognized stock-based compensation expense related to stock options | $     $ 617,219    
Weighted average period of recognition     2 years 6 months    
Shares were withheld for RSUs | shares 82,324        
Omnibus Stock Incentive Plan 2018          
Stockholders' Equity (Deficit)          
Common Stock, Capital Shares Reserved for Future Issuance | shares       14,227 350,000
Vesting period   12 months      
Cash fee paid | $   $ 150,000      
Restricted stock units          
Stockholders' Equity (Deficit)          
Unrecognized stock-based compensation expense | $     $ 8,500,000    
Weighted average period of recognition     2 years